139 related articles for article (PubMed ID: 25573436)
1. Case of non-Herlitz junctional epidermolysis bullosa with COL17A1 mutation.
Kasai H; Sasaki T; Matsuzaki H; Yoshioka T; Nagao K; Amagai M; Ishiko A; Kubo A
J Dermatol; 2015 Mar; 42(3):323-5. PubMed ID: 25573436
[No Abstract] [Full Text] [Related]
2. Severe phenotype of junctional epidermolysis bullosa generalised intermediate type caused by homozygous COL17A1:c.505C>T (p.Arg169*) mutation.
Vaz SO; Dâmaso C; Liu L; Ozoemena L; Mota-Vieira L
Eur J Dermatol; 2018 Jun; 28(3):412-413. PubMed ID: 29952287
[No Abstract] [Full Text] [Related]
3. A de novo COL17A1 splice-site mutation causing a 7-bp deletion in a Taiwanese patient with junctional epidermolysis bullosa.
Hou PC; Tu WT; Chen PC; Guevara BEK; Yen YF; Huang HY; Lee JY; Tang MJ; Kuo PL; Mcgrath JA; Hsu CK
Eur J Dermatol; 2021 Apr; 31(2):267-269. PubMed ID: 34001479
[No Abstract] [Full Text] [Related]
4. Late-onset skin fragility in childhood: a case of junctional epidermolysis bullosa of late onset caused by a missense mutation in COL17A1.
Vanotti S; Chiaverini C; Charlesworth A; Bonnet N; Berbis P; Meneguzzi G; Lacour JP
Br J Dermatol; 2013 Sep; 169(3):714-5. PubMed ID: 23550562
[No Abstract] [Full Text] [Related]
5. Gentamicin induces COL17A1 nonsense mutation readthrough in junctional epidermolysis bullosa.
Li Y; Shen J; Liang J; Zheng L; Chen F; Yao Z; Li M
J Dermatol; 2020 Mar; 47(3):e82-e83. PubMed ID: 31919892
[No Abstract] [Full Text] [Related]
6. Identification of a Novel COL17A1 Compound Heterozygous Mutation in a Chinese Girl with Non-Herlitz Junctional Epidermolysis Bullosa.
Yao YY; Zhang Y; Xie XH; Chen L; Zhu F; Zhou M
Curr Med Sci; 2020 Aug; 40(4):795-800. PubMed ID: 32862392
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant junctional epidermolysis bullosa.
Almaani N; Liu L; Dopping-Hepenstal PJ; Lovell PA; Lai-Cheong JE; Graham RM; Mellerio JE; McGrath JA
Br J Dermatol; 2009 May; 160(5):1094-7. PubMed ID: 19120338
[TBL] [Abstract][Full Text] [Related]
8. New versatile monoclonal antibodies against type XVII collagen endodomain for diagnosis and subtyping COL17A1-associated junctional epidermolysis bullosa.
Yuen WY; Di Zenzo G; Jonkman MF; Pas HH
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1426-7. PubMed ID: 26334130
[No Abstract] [Full Text] [Related]
9. A Silent COL17A1 Variant Alters Splicing and Causes Junctional Epidermolysis Bullosa.
Hoffmann J; Casetti F; Reimer A; Leppert J; Grüninger G; Has C
Acta Derm Venereol; 2019 Apr; 99(4):460-461. PubMed ID: 30673110
[No Abstract] [Full Text] [Related]
10. Retrospective diagnosis of fatal BP180-deficient non-Herlitz junctional epidermolysis bullosa suggested by immunofluorescence (IF) antigen-mapping of parental carriers bearing enamel defects.
Murrell DF; Pasmooij AM; Pas HH; Marr P; Klingberg S; Pfendner E; Uitto J; Sadowski S; Collins F; Widmer R; Jonkman MF
J Invest Dermatol; 2007 Jul; 127(7):1772-5. PubMed ID: 17344927
[No Abstract] [Full Text] [Related]
11. Secrets of the cutaneous basement membrane.
Karpati S
J Invest Dermatol; 2014 Mar; 134(3):602-604. PubMed ID: 24518114
[TBL] [Abstract][Full Text] [Related]
12. A case of junctional epidermolysis bullosa with prurigo-like lesions and reduction of collagen XVII and filaggrin.
Cifuentes L; Kiritsi D; Chen W; Pennino J; Ring J; Weidinger S; Has C
Br J Dermatol; 2013 Jul; 169(1):195-8. PubMed ID: 23834121
[No Abstract] [Full Text] [Related]
13. Focal palmoplantar callosities in non-Herlitz junctional epidermolysis bullosa.
Mitsui H; Watanabe T; Komine M; Nakamura H; Shimizu H; Tamaki K
J Am Acad Dermatol; 2005 Feb; 52(2):371-3. PubMed ID: 15692495
[No Abstract] [Full Text] [Related]
14. The missense mutation p.R1303Q in type XVII collagen underlies junctional epidermolysis bullosa resembling Kindler syndrome.
Has C; Kiritsi D; Mellerio JE; Franzke CW; Wedgeworth E; Tantcheva-Poor I; Kernland-Lang K; Itin P; Simpson MA; Dopping-Hepenstal PJ; Fujimoto W; McGrath JA; Bruckner-Tuderman L
J Invest Dermatol; 2014 Mar; 134(3):845-849. PubMed ID: 24005051
[No Abstract] [Full Text] [Related]
15. Junctional epidermolysis bullosa of late onset explained by mutations in COL17A1.
Yuen WY; Pas HH; Sinke RJ; Jonkman MF
Br J Dermatol; 2011 Jun; 164(6):1280-4. PubMed ID: 21466533
[TBL] [Abstract][Full Text] [Related]
16. Genotypic and phenotypic analysis of 34 cases of inherited junctional epidermolysis bullosa caused by COL17A1 mutations.
Hérissé AL; Charlesworth A; Bellon N; Leclerc-Mercier S; Bourrat E; Hadj-Rabia S; Bodemer C; Lacour JP; Chiaverini C
Br J Dermatol; 2021 May; 184(5):960-962. PubMed ID: 33393081
[No Abstract] [Full Text] [Related]
17. Next generation sequencing identifies double homozygous mutations in two distinct genes (EXPH5 and COL17A1) in a patient with concomitant simplex and junctional epidermolysis bullosa.
Vahidnezhad H; Youssefian L; Saeidian AH; Touati A; Sotoudeh S; Jazayeri A; Guy A; Lovell PA; Liu L; Kariminejad A; McGrath JA; Zeinali S; Uitto J
Hum Mutat; 2018 Oct; 39(10):1349-1354. PubMed ID: 30016581
[TBL] [Abstract][Full Text] [Related]
18. Localized and generalized forms of blistering in junctional epidermolysis bullosa due to COL17A1 mutations in the Netherlands.
Pasmooij AM; Pas HH; Jansen GH; Lemmink HH; Jonkman MF
Br J Dermatol; 2007 May; 156(5):861-70. PubMed ID: 17263807
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa.
Kiritsi D; Kern JS; Schumann H; Kohlhase J; Has C; Bruckner-Tuderman L
J Med Genet; 2011 Jul; 48(7):450-7. PubMed ID: 21357940
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification of collagen 17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice.
Sproule TJ; Bubier JA; Grandi FC; Sun VZ; Philip VM; McPhee CG; Adkins EB; Sundberg JP; Roopenian DC
PLoS Genet; 2014 Feb; 10(2):e1004068. PubMed ID: 24550734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
